Neurology® Podcast

Dr. Jeff Ratliff talks with Dr. Chris Gibbons about the use of skin biopsies to detect phosphorylated α-synuclein in individuals with synucleinopathies such as Parkinson disease, multiple system atrophy, dementia with Lewy bodies, and pure autonomic failure. Read the related article in JAMA. Disclosures can be found at Neurology.org.

As part of our "Physician as Patient" series, Dr. Andy Southerland talks with Dr. Amy Hessler about her experience with a ruptured arteriovenous malformation as a 2nd-year neurology resident. Disclosures can be found at Neurology.org.

As part of our "Physician as Patient" series, Dr. Andy Southerland talks with Dr. Joe Sirven about his experience with a ruptured arteriovenous malformation. If you're attending the AAN Annual Meeting in Denver, you can catch this conversation and more in a live Q&A session on April 16th at 2:30 pm MT at the publication stage. Disclosures can be found at Neurology.org.

Dr. Jeff Ratliff talks with Drs. Dara V. F. Albert and Afsaneh Talai about understanding the gaps in resident education on psychogenic nonepileptic seizures. Read the related article in Neurology: Education. Disclosures can be found at Neurology.org.

Dr. Kait Nevel talks with Dr. Elizabeth Gerstner about the use of CAR-T cells in the treatment of glioblastoma. Read the related article in The New England Journal of Medicine. Disclosures can be found at Neurology.org.

Dr. Justin Abbatemarco talks with Dr. Géraldine Androdias about the impact of immune checkpoint inhibitors on the course of multiple sclerosis. Read the related article in Neurology: Neuroimmunology and Neuroinflammation. Disclosures can be found at Neurology.org.

Dr. Jessica Ailani talks with Dr. Ron (W.P.J.) van Oosterhout about the occurrence, characteristics, and evolution of space headaches during long-duration flights. Read the related article in Neurology. Disclosures can be found at Neurology.org.

The April 2024 replay of past episodes showcases four incredible interviews on functional neurologic disorders. The episode begins with the 3-part FND roundtable discussion with Prof Jon Stone discussing various topics in FND with Drs. Selma Aybek, David Perez, and Sarah Lidstone. In the first discussion they touch on FND diagnosis and exploring new phenotypes. The second discussion is on how and why FND and the third discussion is on treatments for FND. The episode concludes with Dr. Halley Alexander’s conversation with Dr. Genna Waldman about reviewing psychogenic non-epileptic events. Related Links: An Updated Round Table Discussion on FND: Diagnosis of FND and New PhenotypesAn Updated Round Table Discussion on FND: How and Why Does FND Occur?An Updated Round Table Discussion on FND: Sharing a Diagnosis and TreatmentReviewing Psychogenic Non-Epileptic Events Disclosures can be found at Neurology.org.

Dr. Shuvro Roy talks with Dr. Annette Langer-Gould about the effective dose of rituximab and other B-cell depleting therapies in patients with multiple sclerosis, as well as important comorbidities to prevent infection risks. Read the related article in Neurology: Neuroimmunology and Neuroinflammation. Disclosures can be found at Neurology.org.

Dr. Jeff Ratliff speaks with Dr. Avindra Nath, the recipient of the 2024 American Brain Foundation Ted Burns Humanism in Neurology Award. Read more about the Ted Burns Humanism in Neurology Award. Disclosures can be found at Neurology.org.

Dr. Halley Alexander talks with Dr. Valérie van Hezik-Wester about whether people living with severe medically refractory epilepsy (PSRE) benefit from a seizure dog. Read the related article in Neurology. Disclosures can be found at Neurology.org.

Dr. Halley Alexander talks with Dr. Genevieve Rayner and Eliza Honybun about the relationship between prenatal antiseizure medication exposure and adverse postnatal neurodevelopmental outcomes. Read the related article in Neurology. Disclosures can be found at Neurology.org.

Dr. Jason Crowell talks with Dr. Carles Gaig about developing a composite score to assess the severity of the multiple symptoms present in anti-IgLON5 disease. Read the related article in Neurology. Disclosures can be found at Neurology.org.

Dr. Stacey Clardy talks with Aaron Baldwin about how access to genetic testing may vary based on various factors such as race, ethnicity, sex, socioeconomic status, and insurance status. Read the related article in Neurology. Disclosures can be found at Neurology.org.

Dr. Deanna Saylor talks with Drs. Gretchen Birbeck and Melody Asukile about ways to improve global collaboration among neurologists. Read the related article in JAMA Neurology. Disclosures can be found at Neurology.org.

Dr. Howard Goodkin talks with Dr. Fred Lado about the National Association of Epilepsy Centers (NAEC) updated guidelines for specialized epilepsy centers. Read the related article in Neurology. Disclosures can be found at Neurology.org.

The March 2024 recall includes three episodes taken from the 2023 November Headache Series. In part two of this two-part recall, Dr. Tesha Monteith begins with a discussion with Dr. Messoud Ashina on the mechanisms of migraine. The episode continues with Dr. Peter Goadsby talking about updates on migraine treatments and CGRP inhibitors. Finally, the episode concludes with an interview with Dr. Stewart Tepper discussing rapid developments in neuromodulation. Related Podcast Links: https://directory.libsyn.com/episode/index/id/28721028 https://directory.libsyn.com/episode/index/id/28812568 https://directory.libsyn.com/episode/index/id/28868248 Disclosures can be found at Neurology.org

Dr. Tesha Monteith talks with Dr. Robert Evan Shapiro about the impact that migraine has on quality of life and the frequency of migraine-related stigma. Read the related article in Neurology. Disclosures can be found at Neurology.org.

Dr. Shuvro Roy talks with Dr. Riley Bove about managing patients with multiple sclerosis as they navigate family planning and pregnancy. Read the related article in Neurology: Clinical Practice. Disclosures can be found at Neurology.org.

Dr. Jason Crowell talks with Dr. Subhojit Roy about a platform for investigating the role of serine-129 in synucleinopathies, with implications for drug development. Read the related article in the Neuron. Disclosures can be found at Neurology.org.